Does new approach to treating pollenosis -- a pilot study?
Patients receiving the homoeopathic drug combination experienced improvements without side effects. Whether this improvement is due to the medicine or some other factor would need to be determined in a controlled trial.
In our series, the infection risk associated with revision of malfunctioning devices was no greater than primary implant placement. Rerouting was associated with a higher infection risk, likely due to technical factors, and not implant colonization. Less than 10% of our revision implants were colonized, and this had no bearing on the development of a postoperative infection. S. epidermidis was not the most common organism implicated in device infections. Finally, our experience with an adjuvant, alcohol-based skin prep warrants further randomized prospective evaluation.